Biofil Chemicals Reports Strong Q1 FY27 Results; Plans Manufacturing Upgradation
Biofil Chemicals & Pharmaceuticals Limited has announced the Un-Audited Financial Results for the quarter ended June 30, 2026. The Board of Directors reviewed and approved these results alongside a limited Review Report from the statutory auditors.The company reported robust performance in the first quarter of the financial year, with its net sales/income from operations reaching 1,235.02 Lakhs for the period.Financial Highlights and Segment Performance
The quarterly results were reviewed by the Audit Committee and approved by the Board, adhering to Indian Accounting Standard (Ind AS). The company reported two business segments: Pharma Division and...